Skip to content
HowShorted

Accendra Health, Inc. short interest in 2018

In 2018, Accendra Health, Inc.'s disclosed short interest ran from 13.90% of shares outstanding on 12 Jan 2018 to 15.45% on 31 Dec 2018, a change of +1.55 percentage points. The year's high was 17.76% on 15 Jun 2018 and its low 10.43% on 15 Nov 2018, averaging 15.64% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.77 days on 31 May 2018. Full history: Accendra Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for Accendra Health, Inc. in 2018

2018 in figures

Start of year
13.90% (12 Jan 2018)
End of year
15.45% (31 Dec 2018)
Change
+1.55 pp
High
17.76% (15 Jun 2018)
Low
10.43% (15 Nov 2018)
Average
15.64%
Highest days to cover
20.77 (31 May 2018)
SEC filings marked
9

Every report in 2018

Accendra Health, Inc. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 201813.90%9.69
31 Jan 201816.49%7.49
15 Feb 201817.15%4.18results (8-K), results (8-K)
28 Feb 201816.47%5.5110-K filed
15 Mar 201816.44%10.08
29 Mar 201815.89%4.90
13 Apr 201816.17%16.15
30 Apr 201816.01%11.55
15 May 201815.63%10.5510-Q filed, results (8-K)
31 May 201817.09%20.77
15 Jun 201817.76%12.45
29 Jun 201817.65%14.93
13 Jul 201817.05%19.43
31 Jul 201816.10%15.97
15 Aug 201816.99%6.11results (8-K), 10-Q filed
31 Aug 201815.76%12.30
14 Sep 201813.93%10.33
28 Sep 201815.18%12.42
15 Oct 201815.90%11.60
31 Oct 201816.38%6.31results (8-K)
15 Nov 201810.43%4.0610-Q filed
30 Nov 201811.54%5.29
14 Dec 201813.92%6.40
31 Dec 201815.45%4.41

See also: Accendra Health, Inc.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.